RxDoctor Payments Data

Dennis Streeter, DO

Surgery · Merrillville, INNPI 1912994773

Payments from drug & device makers

$1,121in general payments, 2019–2025

Across 42 payments — averaging $26.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$236
  • Genentech USA, Inc.$169
  • Coopersurgical, Inc.$102
  • KCI USA, Inc.$74
  • Smith+Nephew$61
  • Gilead$60
  • plus $419 from 16 others

What the payments were for

  • Food & beverage$1,121100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,121 in reported general payments places this provider in the 40th percentile of 524 surgery providers in Indiana.

See all surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$130,388
Medicare patients
180
Services billed
1,810

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Np ThyroidThyroid,pork47$2,211
Liothyronine Sodium35$2,076
ProgesteroneProgesterone, Micronized26$1,102
Levothyroxine Sodium84$830
LantusInsulin Glargine,hum.Rec.Anlog12$739
SynthroidLevothyroxine Sodium48$648
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid64$597
Metoprolol Succinate31$412
Losartan Potassium34$350
Metformin Hcl42$232
Allopurinol18$203
Lisinopril12$180
Fluticasone Propionate14$154
Hydrochlorothiazide23$149
Metoprolol Tartrate31$136

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$236$64848 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 524 surgery providers in Indiana.

Other surgery in Merrillville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →